Aug-06
AUTHORS : Dr Annalisa Rubino (Details for study: RTI Health Solutions), Astrazeneca, Cambridge, United Kingdom – Email: annalisa.rubino@astrazeneca.com
JOURNAL : Pharmacoepidemiology and Drug Safety
REFERENCE: 15(S1):S51
DOI : 10.1002/pds.1295